Insufficient evidence to conclude whether anti-tumor necrosis factor therapy increases the risk of lymphoma in Crohn's disease.
Peyrin-Biroulet
Laurent
L
Colombel
Jean-Frederic
JF
Sandborn
William J
WJ
D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008223:Lymphoma / Q000139:chemically induced*; D018570:Risk Assessment; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha